4 takeaways from STAT’s story on the development of malaria vaccines
For the first time, the world is starting to roll out malaria vaccines to children in sub-Saharan Africa. The story of the development of those vaccines, a decades-long effort that stretched from labs in New York, England, and Belgium to clinical research sites in a number of African countries, is detailed in a STAT special report published Thursday.
Below are four takeaways about what the history of the malaria shots shows about vaccine development, particularly for neglected diseases that primarily affect low-income countries.
Read Original Article: 4 takeaways from STAT’s story on the development of malaria vaccines »
